Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial
The early clinical data is suggestive, and the research community continues to investigate their potential applications
Body composition and needle length The simple rule: leaner people need shorter needles, people with more subcutaneous fat can use slightly longer options
Ozempic and other GLP-1 mimics have been heralded as the medical sensation of the decade, the end of obesity, and game-changing miracle drugs
Take charge of your health journey at Sova.Health, where personal care meets results
Muscle absorption is then significantly less effective